VALORY PAVLIK

TitleAssociate Professor
InstitutionBaylor College of Medicine
DepartmentDepartment of Neurology
Address7200 CAMBRIDGE
Houston, TX 77030
vCardDownload vCard

    Collapse Research 
    Collapse research activities and funding
    R21DK062098     (PAVLIK, VALORY N)Aug 15, 2004 - Jul 31, 2007
    NIH/NIDDK
    Cross-Cultural Validity of Cognitive Function Tests
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Pavlik VN, Burnham SC, Kass JS, Helmer C, Palmqvist S, Vassilaki M, Dartigues JF, Hansson O, Masters CL, Pérès K, Petersen RC, Stomrud E, Butler L, Coloma PM, Teitsma XM, Doody R, Sano M. Connecting Cohorts to Diminish Alzheimer's Disease (CONCORD-AD): A Report of an International Research Collaboration Network. J Alzheimers Dis. 2021 Nov 08. PMID: 34776434.
      Citations:    Fields:    
    2. Sood A, Pavlik V, Darby E, Chan W, Doody R. Different Cognitive Profiles Are Associated with Progression Rate and Age at Death in Probable Alzheimer's Disease. J Alzheimers Dis. 2021; 80(2):735-747. PMID: 33579838.
      Citations:    Fields:    Translation:Humans
    3. Pavlik VN, Chan W, Darby E. Cohort Effects in Progression Rate on Cognitive and Functional Measures in an Alzheimer's Disease Clinical Cohort. J Alzheimers Dis. 2019; 71(2):659-669. PMID: 31424408.
      Citations:    Fields:    Translation:Humans
    4. Hyman DJ, Pavlik V. Controlling Hypertension: We Have the Tools-We Just Need to Use Them. J Gen Intern Med. 2017 08; 32(8):860-862. PMID: 28455646.
      Citations:    Fields:    Translation:Humans
    5. Hawk M, Nowalk MP, Moehling KK, Pavlik V, Raviotta JM, Brown AE, Zimmerman RK, Ricci EM. Using a Mixed Methods Approach to Examine Practice Characteristics Associated With Implementation of an Adult Immunization Intervention Using the 4 Pillars Practice Transformation Program. J Healthc Qual. 2017 May/Jun; 39(3):153-167. PMID: 28166113.
      Citations: 2     Fields:    Translation:HumansPHPublic Health
    6. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 11416630.
      Citations: 2     Fields:    
    7. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 30552298.
      Citations: 5     Fields:    Translation:Humans
    8. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 34615363.
      Citations: 1     Fields:    
    9. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 20178566.
      Citations: 28     Fields:    
    10. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 17950409.
      Citations: 66     Fields:    Translation:HumansPHPublic Health
    11. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 15724769.
      Citations: 1     Fields:    Translation:Humans
    12. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 14513983.
      Citations: 1     Fields:    Translation:Humans
    13. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 19845950.
      Citations: 52     Fields:    
    14. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 16449393.
      Citations: 45     Fields:    Translation:Humans
    15. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 21252542.
      Citations: 12     Fields:    Translation:Humans
    16. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 24004698.
      Citations: 2     Fields:    Translation:Humans
    17. Zhuang H, Bai J, Chang JY, Yuan Z, Wang P. MTOR inhibition reversed drug resistance after combination radiation with erlotinib in lung adenocarcinoma. Oncotarget. 2016 Dec 20; 7(51):84688-84694. PMID: 25188617.
      Citations: 4     Fields:    Translation:HumansPHPublic Health
    18. Lin CJ, Nowalk MP, Pavlik VN, Brown AE, Zhang S, Raviotta JM, Moehling KK, Hawk M, Ricci EM, Middleton DB, Patel S, South-Paul JE, Zimmerman RK. Using the 4 pillars™ practice transformation program to increase adult influenza vaccination and reduce missed opportunities in a randomized cluster trial. BMC Infect Dis. 2016 Nov 03; 16(1):623. PMID: 27809793.
      Citations: 8     Fields:    Translation:HumansPHPublic Health
    19. Zimmerman RK, Brown AE, Pavlik VN, Moehling KK, Raviotta JM, Lin CJ, Zhang S, Hawk M, Kyle S, Patel S, Ahmed F, Nowalk MP. Using the 4 Pillars Practice Transformation Program to Increase Pneumococcal Immunizations for Older Adults: A Cluster-Randomized Trial. J Am Geriatr Soc. 2017 01; 65(1):114-122. PMID: 27755655.
      Citations: 12     Fields:    Translation:HumansPHPublic Health
    20. Nowalk MP, Lin CJ, Pavlik VN, Brown AE, Zhang S, Moehling KK, Raviotta JM, South-Paul JE, Hawk M, Ricci EM, Middleton DB, Patel SA, Ahmed F, Zimmerman RK. Using the 4 Pillars™ Practice Transformation Program to increase adult Tdap immunization in a randomized controlled cluster trial. Vaccine. 2016 09 22; 34(41):5026-5033. PMID: 27576073.
      Citations: 7     Fields:    Translation:HumansPHPublic Health
    21. Doody RS, Demirovic J, Ballantyne CM, Chan W, Barber R, Powell S, Pavlik V. Lipoprotein-associated phospholipase A2, homocysteine, and Alzheimer's disease. Alzheimers Dement (Amst). 2015 Dec; 1(4):464-71. PMID: 27239525.
      Citations: 10     
    22. Pavlik VN, Chan W, Hyman DJ, Feldman P, Ogedegbe G, Schwartz JE, McDonald M, Einhorn P, Tobin JN. Designing and evaluating health systems level hypertension control interventions for African-Americans: lessons from a pooled analysis of three cluster randomized trials. Curr Hypertens Rev. 2015; 11(2):123-31. PMID: 25808682.
      Citations: 9     Fields:    Translation:Humans
    23. Pavlik V, Brown AE, Nash S, Gossey JT. Association of patient recall, satisfaction, and adherence to content of an electronic health record (EHR)-generated after visit summary: a randomized clinical trial. J Am Board Fam Med. 2014 Mar-Apr; 27(2):209-18. PMID: 24610183.
      Citations: 15     Fields:    Translation:Humans
    24. Grigoryan L, Pavlik VN, Hyman DJ. Characteristics, drug combinations and dosages of primary care patients with uncontrolled ambulatory blood pressure and high medication adherence. J Am Soc Hypertens. 2013 Nov-Dec; 7(6):471-6. PMID: 23890931.
      Citations: 15     Fields:    Translation:Humans
    25. Brown AE, Tonigan JS, Pavlik VN, Kosten TR, Volk RJ. Spirituality and confidence to resist substance use among celebrate recovery participants. J Relig Health. 2013 Mar; 52(1):107-13. PMID: 21246280.
      Citations: 2     Fields:    Translation:Humans
    26. Pavlik V, Massman P, Barber R, Doody R. Differences in the association of peripheral insulin and cognitive function in non-diabetic Alzheimer's disease cases and normal controls. J Alzheimers Dis. 2013; 34(2):449-56. PMID: 23241558.
      Citations: 3     Fields:    Translation:Humans
    27. Grigoryan L, Pavlik VN, Hyman DJ. Patterns of nonadherence to antihypertensive therapy in primary care. J Clin Hypertens (Greenwich). 2013 Feb; 15(2):107-11. PMID: 23339728.
      Citations: 7     Fields:    Translation:Humans
    28. Proschan M, Ford CE, Cutler JA, Graumlich JF, Pavlik V, Cushman WC, Davis BR, Alderman MH, Gordon D, Furberg CD, Franklin SS, Blumenthal SS, Castaldo RS, Preston RA. How much effect of different antihypertensive medications on cardiovascular outcomes is attributable to their effects on blood pressure? Stat Med. 2013 Feb 28; 32(5):884-97. PMID: 22961832.
      Citations: 2     Fields:    Translation:Humans
    29. Pavlik V. Comment: serum ceramides--a new biomarker for preclinical AD? Neurology. 2012 Aug 14; 79(7):639. PMID: 22815553.
      Citations:    Fields:    Translation:Humans
    30. Rountree SD, Chan W, Pavlik VN, Darby EJ, Doody RS. Factors that influence survival in a probable Alzheimer disease cohort. Alzheimers Res Ther. 2012 May 15; 4(3):16. PMID: 22594761.
      Citations: 13     Fields:    
    31. Grigoryan L, Pavlik VN, Hyman DJ. Predictors of antihypertensive medication adherence in two urban health-care systems. Am J Hypertens. 2012 Jul; 25(7):735-8. PMID: 22441507.
      Citations: 10     Fields:    Translation:Humans
    32. Mansyur CL, Pavlik VN, Hyman DJ, Taylor WC, Goodrick GK. Self-efficacy and barriers to multiple behavior change in low-income African Americans with hypertension. J Behav Med. 2013 Feb; 36(1):75-85. PMID: 22322910.
      Citations: 16     Fields:    Translation:Humans
    33. Hyman DJ, Pavlik VN, Greisinger AJ, Chan W, Bayona J, Mansyur C, Simms V, Pool J. Effect of a physician uncertainty reduction intervention on blood pressure in uncontrolled hypertensives--a cluster randomized trial. J Gen Intern Med. 2012 Apr; 27(4):413-9. PMID: 22033742.
      Citations: 15     Fields:    Translation:Humans
    34. Pavlik VN, Doody RS. Progress in understanding variability in cognitive responses to cholinesterase inhibitor treatment. Alzheimers Res Ther. 2011 Oct 17; 3(5):30. PMID: 21999183.
      Citations: 2     Fields:    
    35. Mielke MM, Haughey NJ, Bandaru VV, Weinberg DD, Darby E, Zaidi N, Pavlik V, Doody RS, Lyketsos CG. Plasma sphingomyelins are associated with cognitive progression in Alzheimer's disease. J Alzheimers Dis. 2011; 27(2):259-69. PMID: 21841258.
      Citations: 52     Fields:    Translation:Humans
    36. Pavlik VN, Doody RS, Rountree SD, Darby EJ. Vitamin E use is associated with improved survival in an Alzheimer's disease cohort. Dement Geriatr Cogn Disord. 2009; 28(6):536-40. PMID: 20016184.
      Citations: 13     Fields:    Translation:Humans
    37. Rustveld LO, Pavlik VN, Jibaja-Weiss ML, Kline KN, Gossey JT, Volk RJ. Adherence to diabetes self-care behaviors in English- and Spanish-speaking Hispanic men. Patient Prefer Adherence. 2009 Nov 03; 3:123-30. PMID: 19936154.
      Citations: 17     
    38. Pavlik VN, Greisinger AJ, Pool J, Haidet P, Hyman DJ. Does reducing physician uncertainty improve hypertension control?: rationale and methods. Circ Cardiovasc Qual Outcomes. 2009 May; 2(3):257-63. PMID: 20031846.
      Citations: 9     Fields:    Translation:Humans
    39. Park KW, Pavlik VN, Rountree SD, Darby EJ, Doody RS. Is functional decline necessary for a diagnosis of Alzheimer's disease? Dement Geriatr Cogn Disord. 2007; 24(5):375-9. PMID: 17914262.
      Citations: 6     Fields:    Translation:Humans
    40. Hyman DJ, Pavlik VN, Taylor WC, Goodrick GK, Moye L. Simultaneous vs sequential counseling for multiple behavior change. Arch Intern Med. 2007 Jun 11; 167(11):1152-8. PMID: 17563023.
      Citations: 72     Fields:    Translation:Humans
    41. Barnes AS, Goodrick GK, Pavlik V, Markesino J, Laws DY, Taylor WC. Weight loss maintenance in African-American women: focus group results and questionnaire development. J Gen Intern Med. 2007 Jul; 22(7):915-22. PMID: 17415617.
      Citations: 29     Fields:    Translation:Humans
    42. Gavagan TF, Smart K, Palacio H, Dyer C, Greenberg S, Sirbaugh P, Fishkind A, Hamilton D, Shah U, Masi G, Ivey RT, Jones J, Chiou-Tan FY, Bloodworth D, Hyman D, Whigham C, Pavlik V, Feigin RD, Mattox K. Hurricane Katrina: medical response at the Houston Astrodome/Reliant Center Complex. South Med J. 2006 Sep; 99(9):933-9. PMID: 17004527.
      Citations: 10     Fields:    Translation:HumansPHPublic Health
    43. Waring SC, Doody RS, Pavlik VN, Massman PJ, Chan W. Survival among patients with dementia from a large multi-ethnic population. Alzheimer Dis Assoc Disord. 2005 Oct-Dec; 19(4):178-83. PMID: 16327343.
      Citations: 34     Fields:    Translation:Humans
    44. Pavlik VN, Hyman DJ, Doody R. Cardiovascular risk factors and cognitive function in adults 30-59 years of age (NHANES III). Neuroepidemiology. 2005; 24(1-2):42-50. PMID: 15459509.
      Citations: 23     Fields:    Translation:Humans
    45. Pavlik VN, Hyman DJ. How well are we managing and monitoring high blood pressure? Curr Opin Nephrol Hypertens. 2003 May; 12(3):299-304. PMID: 12698069.
      Citations: 3     Fields:    Translation:Humans
    46. Hyman DJ, Pavlik VN. Uncontrolled hypertension as a risk for coronary artery disease: patient characteristics and the role of physician intervention. Curr Atheroscler Rep. 2003 Mar; 5(2):131-8. PMID: 12573199.
      Citations: 4     Fields:    Translation:Humans
    47. Pavlik VN, de Moraes SA, Szklo M, Knopman DS, Mosley TH, Hyman DJ. Relation between cognitive function and mortality in middle-aged adults: the atherosclerosis risk in communities study. Am J Epidemiol. 2003 Feb 15; 157(4):327-34. PMID: 12578803.
      Citations: 34     Fields:    Translation:Humans
    48. Harrell R, Toronjo CH, McLaughlin J, Pavlik VN, Hyman DJ, Dyer CB. How geriatricians identify elder abuse and neglect. Am J Med Sci. 2002 Jan; 323(1):34-8. PMID: 11814140.
      Citations: 4     Fields:    Translation:Humans
    49. Hyman DJ, Pavlik VN, Vallbona C. Physician Role in Lack of Awareness and Control of Hypertension. J Clin Hypertens (Greenwich). 2000 Oct; 2(5):324-330. PMID: 11416669.
      Citations: 19     Fields:    
    PAVLIK's Networks
    Click the
    Explore
    buttons for more information and interactive visualizations!
    Concepts (198)
    Explore
    _
    Co-Authors (22)
    Explore
    _
    Similar People (60)
    Explore
    _
    Same Department Expand Description
    Explore
    _
    Physical Neighbors
    _